These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 22728575)

  • 1. Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia.
    Lamarca B
    Minerva Ginecol; 2012 Aug; 64(4):309-20. PubMed ID: 22728575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia.
    Lamarca B
    Minerva Ginecol; 2010 Apr; 62(2):105-20. PubMed ID: 20502423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.
    Possomato-Vieira JS; Khalil RA
    Adv Pharmacol; 2016; 77():361-431. PubMed ID: 27451103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.
    Shah DA; Khalil RA
    Biochem Pharmacol; 2015 Jun; 95(4):211-26. PubMed ID: 25916268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology.
    Palei AC; Spradley FT; Warrington JP; George EM; Granger JP
    Acta Physiol (Oxf); 2013 Jul; 208(3):224-33. PubMed ID: 23590594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia.
    Qu H; Khalil RA
    Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H661-H681. PubMed ID: 32762557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.
    Ali SM; Khalil RA
    Expert Opin Ther Targets; 2015; 19(11):1495-515. PubMed ID: 26294111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preeclampsia and eclampsia: the conceptual evolution of a syndrome.
    Erez O; Romero R; Jung E; Chaemsaithong P; Bosco M; Suksai M; Gallo DM; Gotsch F
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S786-S803. PubMed ID: 35177220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis.
    Palmer KR; Tong S; Kaitu'u-Lino TJ
    Mol Hum Reprod; 2017 Feb; 23(2):69-78. PubMed ID: 27986932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Endothelin System: A Critical Player in the Pathophysiology of Preeclampsia.
    Granger JP; Spradley FT; Bakrania BA
    Curr Hypertens Rep; 2018 Apr; 20(4):32. PubMed ID: 29637419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction.
    Granger JP; Alexander BT; Llinas MT; Bennett WA; Khalil RA
    Microcirculation; 2002 Jul; 9(3):147-60. PubMed ID: 12080413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental Ischemia and Resultant Phenotype in Animal Models of Preeclampsia.
    LaMarca B; Amaral LM; Harmon AC; Cornelius DC; Faulkner JL; Cunningham MW
    Curr Hypertens Rep; 2016 Apr; 18(5):38. PubMed ID: 27076345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia.
    LaMarca B; Parrish MR; Wallace K
    Gend Med; 2012 Jun; 9(3):139-46. PubMed ID: 22498426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction.
    Granger JP; Alexander BT; Llinas MT; Bennett WA; Khalil RA
    Hypertension; 2001 Sep; 38(3 Pt 2):718-22. PubMed ID: 11566964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D Supplementation Prevents Placental Ischemia Induced Endothelial Dysfunction by Downregulating Placental Soluble FMS-Like Tyrosine Kinase-1.
    Ma SL; Tian XY; Wang YQ; Zhang HF; Zhang L
    DNA Cell Biol; 2017 Dec; 36(12):1134-1141. PubMed ID: 28981319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurovascular mechanisms of hypertension in pregnancy.
    Stennett AK; Khalil RA
    Curr Neurovasc Res; 2006 May; 3(2):131-48. PubMed ID: 16719796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension in pregnancy].
    Delmis J
    Lijec Vjesn; 2006; 128(11-12):357-68. PubMed ID: 17212198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of placentation abnormalities in pregnancy-induced hypertension.
    Furuya M; Ishida J; Aoki I; Fukamizu A
    Vasc Health Risk Manag; 2008; 4(6):1301-13. PubMed ID: 19337544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy.
    Brewer J; Liu R; Lu Y; Scott J; Wallace K; Wallukat G; Moseley J; Herse F; Dechend R; Martin JN; Lamarca B
    Hypertension; 2013 Nov; 62(5):886-92. PubMed ID: 24041954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension and pregnancy. Diagnosis, physiopathology and treatment].
    Fournier A; Fievet P; el Esper I; el Esper N; Vaillant P; Gondry J
    Schweiz Med Wochenschr; 1995 Nov; 125(47):2273-98. PubMed ID: 8539576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.